News

American Society of Clinical Oncology (ASCO) 2018 – Poster

June 2, 2018

 A PHASE 1 OPEN-LABEL, SAFETY, PHARMACOKINETIC, AND PRELIMINARY EFFICACY STUDY OF STRO-001, AN ANTI-CD74 ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH ADVANCED B-CELL MALIGNANCIES, NCT03424603

2018 ASCO TIP 2018 final 5_29_18